Proactive Investors - Run By Investors For Investors

Evolution Biotechnologies has secured European-wide patent on dust mite prevention agent

Evolution Biotechnologies CEO David Harper updates Proactive Investors at the 11th Annual Biotech Showcase in San Francisco.

The UK and US based company wants to extend the application of biological control from its proven efficacy in agriculture into biomedical markets. The company says the initial target is a novel, self-amplifying biological control for the house dust mite.

 
Meet ICOx Innovations, Zynerba Pharmaceuticals, Pressure BioSciences Inc. and Alchemist Inc at our event, New York , 30 January 2019. Register here »
View full EVOLU profile View Profile

Evolution Biotechnologies Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use